Bellicum Pharmaceuticals, Inc. BLCM

Set alert

0.07 +0.07 —

Day range unavailable

52-week range unavailable

More statistics

Chart tools

Interval

Chart is warming up

The all-time price history for BLCM has not been loaded yet. Try again in a moment.

Held by insiders 4.20%

Held by institutions 29.30%

Float held by institutions 30.59%

Institutions 36

Top institutional holders
Holder	% held	Shares	Value	Reported
Ikarian Capital, LLC	4.72%	448,101	165.80K	Mar 30, 2023
Long Focus Capital Management, LLC	3.45%	327,692	121.25K	Mar 30, 2023
Baker Brothers Advisors, LLC	2.62%	249,123	92.17K	Mar 30, 2023
Blackrock Inc.	0.80%	75,753	28.03K	Mar 30, 2023
Geode Capital Management, LLC	0.77%	72,770	26.92K	Mar 30, 2023
Vanguard Group, Inc. (The)	0.70%	66,309	24.53K	Mar 30, 2023

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Vanguard Extended Market Index Fund	1.03%	92,861	34.36K	Dec 30, 2022
Vanguard Total Stock Market Index Fund	0.96%	86,517	32.01K	Dec 30, 2022
Fidelity Extended Market Index Fund	0.41%	37,163	13.75K	Feb 27, 2023
Fidelity NASDAQ Composite Index Fund	0.25%	22,867	8.46K	Feb 27, 2023
iShares Core S&P Total U.S. Stock Market ETF	0.07%	6,714	2.48K	Feb 27, 2023
Tekla Life Sciences Investors	0.07%	6,000	2.22K	Dec 30, 2022

BLCM insiders
Insider	Relation	Latest transaction	Date	Shares held
BROWN JAMES FARRELL	Director	Conversion of Exercise of derivative security	Jan 3, 2022	28,384
DALY JAMES M.	Director	Conversion of Exercise of derivative security	Jan 2, 2023	109,873
DAVIS STEPHEN R	Director	Conversion of Exercise of derivative security	Jan 2, 2023	136,854
FAIR RICHARD A.	Chief Executive Officer	Purchase	Mar 16, 2020	0
FOSTER AARON E	Officer	Conversion of Exercise of derivative security	Jan 2, 2020	7,281
HUBER REID M.	Director	Conversion of Exercise of derivative security	Jan 2, 2023	153,179

Ownership